Comparison of three different protocols for dobutamine stress echocardiography: Does the addition of atropine increase complications, and does it improve diagnostic accuracy?

Echocardiography

Volumn 16, Issue 4, 1999, Pages 347-355

  Takeuchi, Masaaki ^a,b   Miura, Yasushi ^a   Sonoda, Shinjou ^a   Kuroiwa, Akio ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Atropine; Complication; Coronary artery disease; Diagnosis; Dobutamine

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART DISEASE; HUMAN; HYPOTENSION; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; THORAX PAIN;

EID: 0033021539     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.1999.tb00824.x     Document Type: Article

References (25)

1. 1. Beleslin BD, Ostojic M, Stepanovic J, et al: Stress echocardiography in the detection of myocardial ischemia: Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168-1176.
2. 2. Marwick T, D'Hondt AM, Baudhuin T, et al: Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-167.
3. 3. Mazeika PK, Nadazdin A, Oakley CM: Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992;19:1203-1211.
4. 4. Sawada SG, Segar DS, Ryan T, et al: Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83:1605-1614.
5. 5. Takeuchi M, Araki M, Nakashima Y, et al: Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease. J Am Soc Echocardiogr 1993;6:593-602.
6. 6. McNeill AJ, Fioretti PM, el-Said SM, et al: Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70:41-46.
7. 7. Ling LH, Pellikka PA, Mahoney DW, et al: Atropine augmentation in dobutamine stress echocardiography: Role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996;28:551-557.
8. 8. Mertes H, Sawada SG, Ryan T, et al: Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: Experience in 1118 patients. Circulation 1993;88:15-19.
9. 9. Poldermans D, Fioretti PM, Boersma E, et al: Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994;73: 456-459.
10. 10. Picano E, Mathias W Jr, Pingitore A, et al: Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study: Echo Dobutamine International Cooperative Study Group. Lancet 1994;344: 1190-1192.
11. 11. Cornel JH, Balk AH, Boersma E, et al: Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996;9:27-32.
12. 12. Hennessy TG, Codd MB, Kane G, et al: Safety of dobutamine stress echocardiography in 474 consecutive studies. Coron Artery Dis 1997;8: 175-178.
13. 13. Secknus MA, Marwick TH: Evolution of dobutamine echocardiography protocols and indications: Safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-1240.
14. 14. Geleijnse ML, Fioretti PM, Roelandt JR: Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997;30:595-606.
15. 15. Takeuchi M, Miura Y, Toyokawa T, et al: The comparative diagnostic value of dobutamine stress echocardiography and thallium stress tomography for detecting restenosis after coronary angioplasty. J Am Soc Echocardiogr 1995; 8:696-702.
16. 16. Takeuchi M, Sonoda S, Miura Y, et al: Reproducibility of dobutamine digital stress echocardiography. J Am Soc Echocardiogr 1997;10: 344-351.
17. 17. Segar DS, Brown SE, Sawada SG, et al: Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992;19:1197-1202.
18. 18. Arnese M, Fioretti PM, Cornel JH, et al: Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: A marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol 1994;73:896-899.
19. 19. Takeuchi M, Sonoda S, Hanada H, et al: Acute myocardial infarction in a patient during dobutamine stress echocardiography. Cathet Cardiovasc Diagn 1997;41:404-406.
20. 20. Pellikka PA, Roger VL, Oh JK, et al: Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm > or = 4 cm in diameter. Am J Cardiol 1996;77:413-416.
21. 21. Lewis WR, Arena FJ, Galloway MT, et al: Acute myocardial infarction associated with dobutamine stress echocardiography. J Am Soc Echocardiogr 1997;10:576-578.
22. 22. Weidmann B, Lepique CU, Jansen W, et al: Myocardial infarction as a complication of dobutamine stress echocardiography. J Am Soc Echocardiogr 1997;10:768-771.
23. 23. Marcovitz PA, Bach DS, Mathias W, et al: Paradoxic hypotension during dobutamine stress echocardiography: Clinical and diagnostic implications. J Am Coll Cardiol 1993;21: 1080-1086.
24. 24. Heinle SK, Tice FD, Kisslo J: Hypotension during dobutamine stress echocardiography: Is it related to dynamic intraventricular obstruction? Am Heart J 1995;130:314-317.
25. 25. Lieberman EB, Heinle SK, Wildermann N, et al: Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? Am Heart J 1995;129:1121-1126.